BOSTON–Lincoln Property Company announced that Dante Angelucci has joined the company as Senior Vice President of Development and Construction. In this position, he oversees asset valuation, strategic positioning, and development of commercial projects across multiple product types in the Greater Boston area.
“In today’s challenging commercial real estate environment, companies require knowledgeable development partners that understand a market’s unique dynamics and fundamentals to deliver creative and profitable real estate solutions,” said Clay Duvall, Co-Chief Executive Officer at Lincoln. “Dante’s years of experience leading development projects across multiple product lines and through various market conditions, complemented by his extensive relationships, will strategically position Lincoln to capitalize on unique opportunities and advance its regional leadership and expertise.”
Mr. Angelucci brings more than 25 years of experience in life science, multifamily, mixed-use, office and industrial real estate development to Lincoln. Throughout his career, he has managed feasibility analysis, site acquisition, permitting, financing, construction, leasing, and property disposition on more than $7 billion worth of highly complex real estate projects.
“We are delighted to have someone of Dante’s vast development and construction experience oversee our New England development’s as we prepare to capitalize on the opportunities ahead,” said Scott Brown, Executive Vice President of Lincoln’s Boston office.
In his role as Senior Vice President of Development and Construction, Mr. Angelucci will contribute to Lincoln’s current development projects in the Greater Boston area, which include:
- Seaport Circle (Parcel H), 650,000 square feet of Class A lab and office space in Boston’s Seaport district;
- Catalyst at Burlington Mall Road, a 107,000 square foot GMP/R&D facility in Burlington;
- 7 Channel (Parcel U), 225,000 square feet of Class A lab and office in Boston’s Seaport district;
- 315 Green Street, a 176,800 square foot state-of-the-art logistics and distribution facility in Wrentham.
Prior to Lincoln, Mr. Angelucci served as the Senior Vice President of Development at Alexandria Real Estate Equities, where he oversaw several notable life science projects, including the development of the Eli Lilly Institute for Genetic Medicine headquarters in Boston Seaport’s Innovation District (15 Necco Street) and Moderna’s headquarters in Kendall Square in Cambridge (325 Binney Street). He also managed the development of the Arsenal on the Charles, a life science campus in Watertown.
Previously, Mr. Angelucci was the Executive Vice President of The Davis Companies Development Group, where he helped grow the ground-up development pipeline to in excess of $2 billion over a four-year period. Notable projects included the Omni Seaport Hotel, a 1054-room luxury hotel, 100 Shawmut, a 138-unit luxury condominium project and 35 Cambridge Park Drive, a Class A research facility in Cambridge.
“As an innovation hub, Boston attracts some of the nation’s leading technology, life sciences, and healthcare companies, making it a strong market that is ripe for strategic and opportunistic new development,” added Mr. Angelucci. “I look forward to collaborating with Lincoln’s established team to execute on both its impressive roster of existing projects as well as creating future opportunities that will contribute to Lincoln’s outstanding reputation.”
